Natco Pharma

Update in progress

NATCOPHARM.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

NATCO Pharma Limited is a Hyderabad-based pharmaceutical company engaged in R&D, manufacturing, and marketing of finished dosage forms, APIs, and intermediates for global markets. Its products span oncology, CNS, pain, cardiovascular care, neurology, cardiology, diabetology, orthopedics (bisphosphonates), gastroenterology (hepatitis therapies), and agrochemicals. The company also offers contract manufacturing services. Established in 1981.

Company score

Sentiment: 0.30; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.51; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.07; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.17; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive